Showing results (1461-1470 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|February 5, 2014
9th annual European Antibody Congress, November 11-13, 2013, Geneva, SwitzerlandJanice M Reichert, Alain Beck, Alexey A Lugovskoy, et al.
Mabs|February 5, 2014
The effect of the neonatal Fc receptor on human IgG biodistribution in miceNancy Chen, Weirong Wang, Scott Fauty, et al.
Mabs|February 5, 2014
Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft modelsKathleen R Whiteman, Holly A Johnson, Michele F Mayo, et al.
Mabs|February 5, 2014
The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamicsSiva Charan Devanaboyina, Sandra M Lynch, Raimund J Ober, et al.
Mabs|April 14, 2017
Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugatesThomas Botzanowski, Stéphane Erb, Oscar Hernandez-Alba, et al.
Mabs|April 6, 2017
Unbiased in-depth characterization of CEX fractions from a stressed monoclonal antibody by mass spectrometryFrançois Griaud, Blandine Denefeld, Manuel Lang, et al.
Mabs|August 10, 2019
Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasisRyo Hatano, Takumi Itoh, Haruna Otsuka, et al.
Mabs|April 2, 2019
Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing FcFabian Richter, Oliver Seifert, Andreas Herrmann, et al.
Mabs|September 19, 2019
Optimization of a calcium-dependent Protein A-derived domain for mild antibody purificationJulia Scheffel, Sara Kanje, Jesper Borin, et al.
Mabs|April 22, 2015
The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar developmentLowell J Brady, Jyoti Velayudhan, Devi B Visone, et al.
Pageof 180